Agent Orange:
Persisting Problems With Communication of Ranch Hand Study Data and Results
T-NSIAD-00-117: Published: Mar 15, 2000. Publicly Released: Mar 15, 2000.
Additional Materials:
- Full Report:
Contact:
(202) 512-3000
contact@gao.gov
Office of Public Affairs
(202) 512-4800
youngc1@gao.gov
Pursuant to a congressional request, GAO discussed its recent reports on the Air Force's Ranch Hand study, which was designed to investigate whether exposure to herbicides in Vietnam led to or would lead to adverse health effects, focusing on: (1) what impact the study has had on veterans' compensation decisions; and (2) how the study disseminated results and data, communicated its limitations, and implemented measures to ensure that it was conducted with scientific independence and appropriate outside scientific oversight.
GAO noted that: (1) the Ranch Hand study has had limited impact on decisions affecting veterans' compensation; (2) its most significant impact so far has been on a decision by the Department of Veterans Affairs to provide compensation to Vietnam veterans' children born with spina bifida, but it has not contributed either positively or negatively to decisions to compensate for any other diseases; (3) the study has also led to increased discussion and further study of the association between herbicide exposure and diabetes; (4) currently, Vietnam veterans with diabetes are not eligible for compensation; (5) the relatively small size of the Ranch Hand population limits the study's ability to detect increases in risks of rare diseases, including many forms of cancer; (6) although the Air Force has conducted many aspects of the study rigorously, GAO found several past and ongoing problems, including delays in the dissemination of some results, limited public access to detailed data, inadequate communication of the study's limitations, failure to implement some measures to ensure rigor and independence, and insufficient outreach to veterans; and (7) though many of these problems have been resolved, they have led some critics to question the openness and credibility of the study.
Jan 14, 2021
-
Prescription Drugs:
Department of Veterans Affairs Paid About Half as Much as Medicare Part D for Selected Drugs in 2017GAO-21-111: Published: Dec 15, 2020. Publicly Released: Jan 14, 2021.
Dec 10, 2020
-
VA Construction:
VA Should Enhance the Lessons-Learned Process for Its Real-Property Donation Pilot ProgramGAO-21-133: Published: Dec 10, 2020. Publicly Released: Dec 10, 2020.
Dec 9, 2020
-
VA Disability Benefits:
Process for Identifying Conditions Presumed to be Service Connected and Challenges in Processing Complex Gulf War Illness ClaimsGAO-21-253T: Published: Dec 9, 2020. Publicly Released: Dec 9, 2020.
Nov 12, 2020
-
Veterans Health Care:
Agency Efforts to Provide and Study Prosthetics for Small but Growing Female Veteran PopulationGAO-21-60: Published: Nov 12, 2020. Publicly Released: Nov 12, 2020.
Sep 30, 2020
-
VA Health Care:
Additional Steps Could Help Improve Community Care Budget EstimatesGAO-20-669: Published: Sep 30, 2020. Publicly Released: Sep 30, 2020. -
Veterans Community Care Program:
Improvements Needed to Help Ensure Timely Access to CareGAO-20-721T: Published: Sep 30, 2020. Publicly Released: Sep 30, 2020.
Sep 28, 2020
-
Veterans Community Care Program:
Improvements Needed to Help Ensure Timely Access to CareGAO-20-643: Published: Sep 28, 2020. Publicly Released: Sep 28, 2020.
Sep 21, 2020
-
VA Disability Benefits:
VA Should Continue to Improve Access to Quality Disability Medical Exams for Veterans Living AbroadGAO-20-620: Published: Sep 21, 2020. Publicly Released: Sep 21, 2020.
Sep 16, 2020
-
VA Acquisition Management:
COVID-19 Response Strains Supply Chain While Modernization Delays ContinueGAO-20-716T: Published: Sep 16, 2020. Publicly Released: Sep 16, 2020.
Sep 9, 2020
-
Veteran Suicide:
VA Needs Accurate Data and Comprehensive Analyses to Better Understand On-Campus SuicidesGAO-20-664: Published: Sep 9, 2020. Publicly Released: Sep 9, 2020.
Looking for more? Browse all our products here